WO2001090143A3 - Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions - Google Patents

Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions Download PDF

Info

Publication number
WO2001090143A3
WO2001090143A3 PCT/EP2001/006457 EP0106457W WO0190143A3 WO 2001090143 A3 WO2001090143 A3 WO 2001090143A3 EP 0106457 W EP0106457 W EP 0106457W WO 0190143 A3 WO0190143 A3 WO 0190143A3
Authority
WO
WIPO (PCT)
Prior art keywords
bordetella
pertactin
parapertussis
bronchiseptica
pertussis
Prior art date
Application number
PCT/EP2001/006457
Other languages
French (fr)
Other versions
WO2001090143A2 (en
Inventor
Nicole Guiso-Maclouf
Caroline Boursaux-Eude
Original Assignee
Pasteur Institut
Nicole Guiso-Maclouf
Caroline Boursaux-Eude
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Nicole Guiso-Maclouf, Caroline Boursaux-Eude filed Critical Pasteur Institut
Priority to AU2001267527A priority Critical patent/AU2001267527A1/en
Priority to JP2001586330A priority patent/JP2003533990A/en
Priority to DK01945261T priority patent/DK1284993T3/en
Priority to EP01945261A priority patent/EP1284993B1/en
Priority to DE60133734T priority patent/DE60133734T2/en
Publication of WO2001090143A2 publication Critical patent/WO2001090143A2/en
Publication of WO2001090143A3 publication Critical patent/WO2001090143A3/en
Priority to US10/302,896 priority patent/US6964767B2/en
Priority to CY20081100716T priority patent/CY1110430T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Pertactin (PRN) is an outer membrane protein expressed by Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, which induces protective immunity to Bordetella infections. The immunodominant and immunoprotective epitopes of pertactin include two repeated regions, I and II. Comparison of these two repeated regions showed the pertactin of B. parapertussis) is invariant, whereas the pertactin of B. pertussis varies mostly in region I and B. bronchiseptica varies in both the repeated regions I and II. Compositions containing pertactins and pertactin fragments containing variant sequences in these regions are useful as immunogenic compositions.
PCT/EP2001/006457 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions WO2001090143A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2001267527A AU2001267527A1 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
JP2001586330A JP2003533990A (en) 2000-05-25 2001-05-23 Polypeptides having a polymorphism in the pertactin repetitive region of B. pertussis, B. parapertussis and B. bronchiseptica and their use in diagnostic and immunogenic compositions
DK01945261T DK1284993T3 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeat regions of pertactin from bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica, their use in diagnostics and in immunogenic preparations
EP01945261A EP1284993B1 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
DE60133734T DE60133734T2 (en) 2000-05-25 2001-05-23 POLYPEPTIDES THE POLYMORPHISMS CONTAINING BORDERTELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS AND BORDETELLA BRONCHISEPTICA PERTACTIN REPEATED REGIONS, THEIR USE IN DIAGNOSTIC AND IMMUNOGENIC COMPOSITIONS
US10/302,896 US6964767B2 (en) 2000-05-25 2002-11-25 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
CY20081100716T CY1110430T1 (en) 2000-05-25 2008-07-08 POLYPEPTIDES CONTAINING POLYMORPHIMS OF THE REPEAT REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERUSSIS AND BORDETELLA BRONCHISEPTICA. USE THEREOF IN DIAGNOSTIC AND IMMUNE COMPOSITIONS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25
US60/206,969 2000-05-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/302,896 Continuation US6964767B2 (en) 2000-05-25 2002-11-25 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions

Publications (2)

Publication Number Publication Date
WO2001090143A2 WO2001090143A2 (en) 2001-11-29
WO2001090143A3 true WO2001090143A3 (en) 2002-09-26

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/006457 WO2001090143A2 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Country Status (11)

Country Link
US (3) US7070779B2 (en)
EP (1) EP1284993B1 (en)
JP (1) JP2003533990A (en)
AT (1) ATE393166T1 (en)
AU (1) AU2001267527A1 (en)
CY (1) CY1110430T1 (en)
DE (1) DE60133734T2 (en)
DK (1) DK1284993T3 (en)
ES (1) ES2303833T3 (en)
PT (1) PT1284993E (en)
WO (1) WO2001090143A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (en) * 1989-05-12 1994-06-03 Pasteur Institut USE OF VACCINANT PREPARATIONS BASED ON ADENYL CYCLASE OR OF BACTERIA PRODUCING THEM AS PROTECTIVE ANTIGENS AGAINST THE EFFECTS OF BORDETELLA
DE60133734T2 (en) 2000-05-25 2009-05-14 Institut Pasteur POLYPEPTIDES THE POLYMORPHISMS CONTAINING BORDERTELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS AND BORDETELLA BRONCHISEPTICA PERTACTIN REPEATED REGIONS, THEIR USE IN DIAGNOSTIC AND IMMUNOGENIC COMPOSITIONS
WO2008146830A1 (en) 2007-05-28 2008-12-04 The Kitasato Institute Bordetella parapertussis-containing whole-cell vaccine composition
CU23679A1 (en) * 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech VARIATIONS FOR PERTACTINES FOR VACCINE
EP2430040A1 (en) * 2009-05-11 2012-03-21 Novartis AG Antigen purification process for pertactin antigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
EP2670431A1 (en) * 2011-02-04 2013-12-11 Zoetis LLC Compositions for canine respiratory disease complex
JP5833145B2 (en) * 2011-02-04 2015-12-16 ゾエティス・エルエルシー Immunogenic BORDETELLABRONCHISEPTICA composition
CN109879942A (en) * 2019-03-01 2019-06-14 浙江省农业科学院 A kind of Bordetella Bronchiseptica of Rabbit outer membrane protein and its preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (en) * 1994-12-15 1996-06-21 Pasteur Institut ANTI-BORDETELLA CELL-LIKE VACCINE
DE60133734T2 (en) 2000-05-25 2009-05-14 Institut Pasteur POLYPEPTIDES THE POLYMORPHISMS CONTAINING BORDERTELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS AND BORDETELLA BRONCHISEPTICA PERTACTIN REPEATED REGIONS, THEIR USE IN DIAGNOSTIC AND IMMUNOGENIC COMPOSITIONS

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BOURSAUX-EUDE C ET AL: "POLYMORPHISM OF REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS, AND BORDETELLA BRONCHISEPTICA", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 68, no. 8, August 2000 (2000-08-01), pages 4815 - 4817, XP000971415, ISSN: 0019-9567 *
CAROLINE BOURSAUX-EUDE ET AL.: "Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine", VACCINE, vol. 17, 1999, pages 2651 - 2660, XP004169678 *
CRISTINA PAGLIACCIA ET AL.: "Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point", ARCHIVES OF MICROBIOLOGY, vol. 168, 1997, pages 437 - 440, XP002191967 *
JINGLI LI ET AL.: "Cloning, nucleotide sequence and heterologous expression of the protective outer-membrane protein P.68 pertactin from Bordetella bronchiseptica", JOURNAL OF GENERAL MICROBIOLOGY, vol. 138, 1992, pages 1697 - 1705, XP000974978 *
KAREN B. REGISTER: "Novel genetic and phenotypic heterogeneity in Bordetella bronchiseptica pertactin", INFECTION AND IMMUNITY, vol. 69, no. 3, March 2001 (2001-03-01), pages 1917 - 1921, XP002206752 *
L.J. LI ET AL.: "P.70 pertactin, an outer membrane protein from Bordetella parapertussis: cloning, nucleotide sequence and surface expression in Escherichia coli", MOLECULAR MICROBIOLOGY, vol. 5, no. 2, 1991, pages 409 - 417, XP000283120 *
MOOI F R ET AL: "POLYMORPHISM IN THE BORDETELLA PERTUSSI VIRULENCE FACTORS: P69/PERTACTIN AND PERTUSSIS TOXIN IN THE NETHERLANDS: TEMPORAL TRENDS AND EVIDENCE FOR VACCINE-DRIVEN EVOLUTION", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 66, no. 2, February 1998 (1998-02-01), pages 670 - 675, XP000971410, ISSN: 0019-9567 *
NADIA KHELEF ET AL.: "Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species", INFECTION AND IMMUNITY, vol. 61, no. 2, February 1993 (1993-02-01), pages 486 - 490, XP000971413 *

Also Published As

Publication number Publication date
EP1284993A2 (en) 2003-02-26
ES2303833T3 (en) 2008-09-01
US7070779B2 (en) 2006-07-04
ATE393166T1 (en) 2008-05-15
US7314910B2 (en) 2008-01-01
AU2001267527A1 (en) 2001-12-03
PT1284993E (en) 2008-06-11
DK1284993T3 (en) 2008-07-28
US20030180307A1 (en) 2003-09-25
JP2003533990A (en) 2003-11-18
US20060008474A1 (en) 2006-01-12
WO2001090143A2 (en) 2001-11-29
EP1284993B1 (en) 2008-04-23
US20040166116A9 (en) 2004-08-26
DE60133734T2 (en) 2009-05-14
US20020192237A1 (en) 2002-12-19
DE60133734D1 (en) 2008-06-05
US6964767B2 (en) 2005-11-15
CY1110430T1 (en) 2012-05-23

Similar Documents

Publication Publication Date Title
CY1110430T1 (en) POLYPEPTIDES CONTAINING POLYMORPHIMS OF THE REPEAT REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERUSSIS AND BORDETELLA BRONCHISEPTICA. USE THEREOF IN DIAGNOSTIC AND IMMUNE COMPOSITIONS
WO2006078318A3 (en) Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
MXPA03005222A (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate.
WO2005019255A8 (en) Muteins of tear lipocalin
BR0108711A (en) Heterologous expression of neisserial proteins
WO2002053189A3 (en) Immunogenic complex
MX351247B (en) Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof.
HK1043943A1 (en) Streptococcus pneumoniae proteins and vaccines
GEP20094675B (en) Heteroaryl- tetra-hydropiperidyl compounds useful for treating or preventing pain
MXPA02011370A (en) Substituted iminoazines.
DK2054431T3 (en) Conformers of bacterial adhesins
WO2001008123A8 (en) Derivatized polyurethane compositions and methods of making
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
MXPA02012249A (en) Peptides, compositions and methods for the treatment of burkholderia cepacia.
GB9422990D0 (en) Immunogenic compositions
WO2001083739A3 (en) Human pellino polypeptides
EP1762620A3 (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
WO2003093307A8 (en) Mycobacterial antigens and uses thereof
WO2004053092A3 (en) Human pellino polypeptides
WO2005035794A3 (en) Detection of prrsv
WO2002040518A8 (en) Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
WO2003048304A3 (en) ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF
EP1303300A4 (en) Compositions and methods for treatment of candidiasis
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10302896

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001945261

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001945261

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2001945261

Country of ref document: EP